By Scott Hensley In a decision that shakes the legal foundation for much of the biotech industry, a federal judge has ruled many of a Utah company's patents on a gene test for *** and ovarian cancer are invalid. The case involves patents on two genes
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/03/by_scott_hensley_in_a.html?ft=1&f=103537970
Posted
Mar 30 2010, 06:57 AM
by
NPR Blogs: Shots - Health News